ATE192929T1 - Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis - Google Patents

Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis

Info

Publication number
ATE192929T1
ATE192929T1 AT95904417T AT95904417T ATE192929T1 AT E192929 T1 ATE192929 T1 AT E192929T1 AT 95904417 T AT95904417 T AT 95904417T AT 95904417 T AT95904417 T AT 95904417T AT E192929 T1 ATE192929 T1 AT E192929T1
Authority
AT
Austria
Prior art keywords
apthus
dimeticon
stomatitis
treatment
production
Prior art date
Application number
AT95904417T
Other languages
English (en)
Inventor
Alfred Schmidt
Hans-Juergen Upmeyer
Original Assignee
Alfred Schmidt
Upmeyer Hans Juergen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfred Schmidt, Upmeyer Hans Juergen filed Critical Alfred Schmidt
Application granted granted Critical
Publication of ATE192929T1 publication Critical patent/ATE192929T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
AT95904417T 1993-12-02 1994-12-02 Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis ATE192929T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4341139A DE4341139C1 (de) 1993-12-02 1993-12-02 Dimeticon zur Behandlung von Aphthen
US08/207,066 US5393745A (en) 1993-12-02 1994-03-08 Method for treating aphthae using dimethylpolysiloxane
PCT/EP1994/004023 WO1995015169A1 (en) 1993-12-02 1994-12-02 Use of dimeticone for treating aphthae and stomatitis

Publications (1)

Publication Number Publication Date
ATE192929T1 true ATE192929T1 (de) 2000-06-15

Family

ID=25931728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95904417T ATE192929T1 (de) 1993-12-02 1994-12-02 Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis

Country Status (22)

Country Link
US (1) US5393745A (de)
EP (1) EP0731706B1 (de)
JP (1) JP3895368B2 (de)
AT (1) ATE192929T1 (de)
AU (1) AU705187B2 (de)
BG (1) BG100687A (de)
CA (1) CA2177961C (de)
CZ (1) CZ158096A3 (de)
DE (2) DE4341139C1 (de)
ES (1) ES2150547T3 (de)
HU (1) HU215930B (de)
IL (1) IL111805A (de)
LT (1) LT4122B (de)
MD (1) MD1504F2 (de)
NO (1) NO962259L (de)
NZ (1) NZ277769A (de)
PL (1) PL314800A1 (de)
RU (1) RU2143906C1 (de)
SI (1) SI9420072A (de)
SK (1) SK70196A3 (de)
WO (1) WO1995015169A1 (de)
ZA (1) ZA949563B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100245A (en) * 1999-09-07 2000-08-08 Mcneil-Ppc, Inc. Use of simethicone to treat ulcerative colitis
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
US9511016B2 (en) 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
US8784872B2 (en) 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
RU2464989C2 (ru) * 2010-11-09 2012-10-27 Государственное образовательное учреждение высшего профессионального образования Иркутский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию Способ лечения хронического рецидивирующего афтозного стоматита и средство для его осуществления
RU2444348C1 (ru) * 2010-11-12 2012-03-10 Александр Иванович Майдан Способ аппликационного метода грязелечения
CN104225189A (zh) * 2014-07-24 2014-12-24 烟台瑞智生物医药科技有限公司 一种治疗胃热熏蒸证型经行口糜的中药
CN114206311A (zh) * 2018-11-05 2022-03-18 因斯拜尔材料配方有限责任公司 口腔粘膜载体和保护剂
JP2022522567A (ja) 2018-11-05 2022-04-20 インスパイアド マテリアル ソリューションズ,エルエルシー 真皮保護剤および担体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1194885A (en) * 1967-06-16 1970-06-17 Prev Coat Corp Novel Silicone-Containing Dentifrices
US3507955A (en) * 1968-11-25 1970-04-21 Prev Coat Corp Silicone containing dentifrices
IT1222309B (it) * 1987-07-08 1990-09-05 Menarini Sas Utilizzazione di forme farmaceutiche per uso topico contenenti miocamicina per la terapia delle infezione da germi sensibili alla miocamicina stessa
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
AU637570B2 (en) * 1989-01-19 1993-06-03 Alfred Schmidt Use of dimethylpolysiloxane for treating disorders of the gastrointestinal tract
FR2648346B1 (fr) * 1989-06-20 1993-10-08 Dana Dominique Compositions de dentifrice solide
IE903302A1 (en) * 1989-09-15 1991-04-10 Pehrom Pharmaceutical Corp Topical preparation for treatment of aphthous ulcers and¹other lesions
NO901031L (no) * 1990-03-05 1991-09-06 Gunnar Roella Baktericid sammensetning.
DE4207704A1 (de) * 1992-03-11 1993-09-16 Knut Dr Fischer Verwendung von dimeticon

Also Published As

Publication number Publication date
RU2143906C1 (ru) 2000-01-10
LT4122B (en) 1997-03-25
NZ277769A (en) 1999-09-29
NO962259D0 (no) 1996-05-31
BG100687A (bg) 1997-01-31
NO962259L (no) 1996-06-17
JP3895368B2 (ja) 2007-03-22
DE69424563T2 (de) 2001-01-18
AU1311795A (en) 1995-06-19
WO1995015169A1 (en) 1995-06-08
HU9601496D0 (en) 1996-08-28
HUT75528A (en) 1997-05-28
IL111805A0 (en) 1995-01-24
JPH09509144A (ja) 1997-09-16
EP0731706B1 (de) 2000-05-17
DE4341139C1 (de) 1995-04-13
HU215930B (hu) 1999-03-29
SK70196A3 (en) 1997-03-05
EP0731706A1 (de) 1996-09-18
PL314800A1 (en) 1996-09-30
SI9420072A (en) 1997-02-28
CZ158096A3 (en) 1996-12-11
US5393745A (en) 1995-02-28
ZA949563B (en) 1995-08-16
LT96093A (en) 1996-12-27
CA2177961C (en) 2007-10-23
AU705187B2 (en) 1999-05-20
DE69424563D1 (de) 2000-06-21
IL111805A (en) 1998-09-24
CA2177961A1 (en) 1995-06-08
ES2150547T3 (es) 2000-12-01
MD1504F2 (ro) 2000-07-31

Similar Documents

Publication Publication Date Title
ATE204704T1 (de) Verwendung von bcl-2 zur herstellung von arzneimitteln zur therapeutischen behandlung und verhinderung von krankheiten
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE330593T1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
GEP20002300B (en) Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE69713620D1 (de) Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
ATE269077T1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE69424563D1 (de) Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE59107536D1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
DE3768150D1 (de) Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
BG103926A (bg) Полутвърда фармацевтична форма, съдържаща декскетопрофен трометамол
ATE261735T1 (de) Verwendung von wirkstoffen zur herstellung von arzeinmitteln zur behandlung der rheumatischen arthritis
DE69424415D1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
ATE186640T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen
DE59709081D1 (de) Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
ATA14996A (de) Verwendung von galanthamin zum herstellen von arzneimitteln zur behandlung von trisomie 21 oder verwandter trisomie-syndrome
ATE198831T1 (de) Verwendung von triazinverbindungen zur herstellkung eines arzneimittels zur behandlung von erinnerungs-und lernstörungen
ITGE910094A0 (it) Prodotto per la cura e la prevenzione del cancro e dell'aids

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification